BioXcel Therapeutics (BTAI) Q3 2024 Earnings

Aug 6Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-1.58
-1.12
-0.67
-0.21

Details

Expected EPS
-0.712564
Actual EPS
-0.21
Surprise EPS
0.5
Surprise Percent
+70.53%

Description

⁨BioXcel Therapeutics⁩ (⁦BTAI⁩) has reported earnings of ⁦-0.21⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts